Food and Drug Administration

Dermatologic and Ophthalmic Drugs Advisory Committee Meeting


May 23, 2002

Alefacept BLA Review Committee, Dr. Ezio Bonvini, MD, et. al.  htm  ppt

Alefacept Overview,  Biogen, Inc.  htm  ppt

Clinical Efficacy Overview, Dr. Burt Adelman, MD, et. al., Biogen  htm  ppt

Safety Overview, Dr. Gloria Vigliani, MD, Biogen  htm  ppt

Alefacept Risk Benefit Profile, Dr. Mark Lebwohl, MD, Biogen  htm  ppt

Back-up Information  htm  ppt

Indications and Uses, Dr. Marzella, MD, FDA htm  ppt